Quick quiz may predict survival in elderly cancer patients
NCT ID NCT03449914
First seen Apr 23, 2026 · Last updated May 14, 2026 · Updated 8 times
Summary
This study looks at whether a short, 8-question screening tool called the G8 can help predict survival and severe side effects from treatment in people aged 70 and older with metastatic colorectal cancer. Researchers will also test a physical performance measure called Timed Up and Go. The goal is to find simple ways to guide treatment decisions for older patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELDERLY METASTATIC COLORECTAL CANCER PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istituto Oncologico Veneto IRCCS
Padua, 35128, Italy
Conditions
Explore the condition pages connected to this study.